Rivernorth Capital Management’s Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( CHAQ.WS Stock Holding History
Bought
Maintained
Sold
Rivernorth Capital Management's CHAQ.WS Position: Q3 2021 in Review
Rivernorth Capital Management sold out of Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( (CHAQ.WS) in Q3 2021, closing a stake of 179,886 shares — an estimated $115K sold.
Rivernorth Capital Management first reported a position in CHAQ.WS in Q3 2020 and held it in 4 quarters. The position peaked at $178K in Q4 2020. 0 funds tracked by Wall St. Rank hold CHAQ.WS as of Q3 2021.
- Rivernorth Capital Management reported no remaining Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position as of Q3 2021 after selling out during the quarter.
- Rivernorth Capital Management sold 179,886 Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( shares in Q3 2021, an estimated $115K.
- Rivernorth Capital Management first reported a position in Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( in Q3 2020 and held it in 4 quarters.
- Rivernorth Capital Management's Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( position peaked at $178K in Q4 2020.
- 0 funds tracked by Wall St. Rank held Chardan Healthcare Acquisition 2 Corp. Warrants, entitling the holder thereof to purchase one-half ( as of Q3 2021.
Based on Rivernorth Capital Management's 13F filing for Q3 2021, filed 15 Nov 2021.